Abstract
Modification of nepafenac intermediate synthesis (5A) via Gassman specific ortho-substitution is reported. According to the process, 2-aminobenzophenone (1A) and 2-(methylthio)acetamide (2) were reacted in the convenient temperature conditions, in the presence of N-chlorophthalimide (3) or 1,3-dichloro-5,5-dimethylhydantoin (4), to activate the formation of azasulfonium salt and rearrangement thereof to pure 2-amino-3-benzoyl-α-(methylthio)phenylacetamide (5A). The procedure appears to be suitable for a reaction carried out in a large scale.
Keywords: Gasmann reaction, Nepafenac, N-chlorophthalimide, Sommelet-Hauser-type rearrangement, N-chloroaniline, 2-(methylthio)acetamide, chlorosulfonium, salt, sulfoxide, oxalyl
Letters in Organic Chemistry
Title:Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction
Volume: 9 Issue: 7
Author(s): Marcin Cybulski, Adam Formela, Mariola Mucha, Karolina Klos, Jacek Roszczynski and Jerzy Winiarski
Affiliation:
Keywords: Gasmann reaction, Nepafenac, N-chlorophthalimide, Sommelet-Hauser-type rearrangement, N-chloroaniline, 2-(methylthio)acetamide, chlorosulfonium, salt, sulfoxide, oxalyl
Abstract: Modification of nepafenac intermediate synthesis (5A) via Gassman specific ortho-substitution is reported. According to the process, 2-aminobenzophenone (1A) and 2-(methylthio)acetamide (2) were reacted in the convenient temperature conditions, in the presence of N-chlorophthalimide (3) or 1,3-dichloro-5,5-dimethylhydantoin (4), to activate the formation of azasulfonium salt and rearrangement thereof to pure 2-amino-3-benzoyl-α-(methylthio)phenylacetamide (5A). The procedure appears to be suitable for a reaction carried out in a large scale.
Export Options
About this article
Cite this article as:
Cybulski Marcin, Formela Adam, Mucha Mariola, Klos Karolina, Roszczynski Jacek and Winiarski Jerzy, Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139582
DOI https://dx.doi.org/10.2174/157017812802139582 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Current Neuropharmacology Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill
Current Medicinal Chemistry Microarray Profiling Analysis Uncovers Common Molecular Mechanisms of Rubella Virus, Human Cytomegalovirus, and Herpes Simplex Virus Type 2 Infections in ECV304 Cells
Current Molecular Medicine The Redox Biology of Schistosome Parasites and Applications for Drug Development
Current Pharmaceutical Design Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease
Current Pharmaceutical Design PPARα/HNF4α Interplay on Diversified Responsive Elements. Relevance in the Regulation of Liver Peroxisomal Fatty Acid Catabolism
Current Drug Metabolism Artificial Neural Networks for the Prediction of Response to Interferon Plus Ribavirin Treatment in Patients with Chronic Hepatitis C
Current Pharmaceutical Design Pharmacotherapies for Glaucoma
Current Molecular Medicine IL-27: Friend or Foe in the Autoimmune Diseases
Current Immunology Reviews (Discontinued) Novel Human Plasma Proteins, IHRP (Acute Phase Protein) and PHBP (Serine Protease), Which Bind to Glycosaminoglycans
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Endocannabinoids in Liver Disease and Hepatic Encephalopathy
Current Pharmaceutical Design Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Current Medicinal Chemistry Administration of Drug and Nutritional Components in Nano-Engineered Form to Increase Delivery Ratio and Reduce Current Inefficient Practice
Recent Patents on Drug Delivery & Formulation MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA Novelty in Inflammation and Immunomodulation in Migraine
Current Pharmaceutical Design A Novel Class of Emerging Anticancer Compounds: Oxyprenylated Secondary Metabolites from Plants and Fungi
Current Medicinal Chemistry Effects of Estrogens on Atherogenesis
Current Vascular Pharmacology Mitochondria-Targeted Drugs
Current Molecular Pharmacology Mesenchymal Stem Cells Researches and Clinical Applications in Facial Aging
Current Tissue Engineering (Discontinued) Drug Targets in Stress-Related Disorders
Current Medicinal Chemistry